Description

CJC-1295 NO DAC & Ipamorelin Blend (10mg)

This synergistic blend of CJC-1295 without DAC and Ipamorelin is designed for research into growth hormone release and anti-aging applications. CJC-1295 NO DAC is a shorter-acting GHRH analog that mimics the natural pulsatile release of growth hormone, while Ipamorelin is a selective ghrelin receptor agonist (GHRP) that triggers GH secretion with minimal side effects. Together, they may provide a powerful tool for research into lean muscle growth, fat loss, sleep quality, and recovery.

Properties

Components:
- CJC-1295 (NO DAC) – 5mg
- Ipamorelin – 5mg
CAS Numbers:
- CJC-1295 (NO DAC): 863288-34-0
- Ipamorelin: 170851-70-4
Form: Lyophilized (freeze-dried) peptide powder
Strength: 10mg per vial (5mg + 5mg)
Appearance: White to off-white powder
Storage: Store at -20°C; refrigerate reconstituted solution at 2–8°C
Shelf Life: 36 months (lyophilized); 60 days once reconstituted (if refrigerated)

Benefit

Stimulates natural growth hormone release via dual pathways
Promotes lean muscle mass development
Supports fat metabolism and reduction in adipose tissue
May enhance sleep quality and cellular recovery
Minimal impact on cortisol or prolactin levels (especially from Ipamorelin)

Dosage

For research use only. Standard research protocols involve subcutaneous administration of 100–300mcg of each compound (CJC-1295 NO DAC and Ipamorelin), 1–2 times daily, typically before sleep and/or post-exercise. Reconstitute with bacteriostatic water.